Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol
作者:Franck Amblard、Baskaran Govindarajan、Benjamin Lefkove、Kimberly L. Rapp、Mervi Detorio、Jack L. Arbiser、Raymond F. Schinazi
DOI:10.1016/j.bmcl.2007.06.024
日期:2007.8
A series of new bisphenol derivatives bearing allylic moieties were synthesized as potential analogs of honokiol and/or magnolol. Certain compounds exhibited specific anti-proliferation activity against SVR cells and moderate anti-HIV-1 activity in primary human lymphocytes. Compound 5h was the most potent compound and its anti-tumor activity was evaluated in vivo. Published by Elsevier Ltd.
Preparation of New Derivatives of Diethylstilbestrol and Hexestrol by the Claisen Rearrangement<sup>1</sup>
作者:Emil Kaiser、J. J. Svarz
DOI:10.1021/ja01208a031
日期:1946.4
Vilkas; Epsztein; Sainton, European Journal of Medicinal Chemistry, 1982, vol. 17, # 2, p. 191 - 192
作者:Vilkas、Epsztein、Sainton、Leclercq
DOI:——
日期:——
Derivatives of diethylstilbestrol
申请人:ARMOUR & CO
公开号:US02502324A1
公开(公告)日:1950-03-28
Honokiol Derivates For the Treatment of Proliferative Disorders
申请人:Arbiser Jack L.
公开号:US20080300298A1
公开(公告)日:2008-12-04
The present invention provides novel honokiol derivatives, as well as pharmaceutical compositions containing the honokiol derivatives. These compounds and pharmaceutical compositions can be used in the prevention and/or treatment of cancer. In particular, honokiol derivatives, pharmaceutical compositions comprising the derivatives, and methods for their use in the treatment of myeloma are provided.